Justices expected to issue an order on Wednesday in case from anti-abortioners seeking to roll back approval of mifepristone
The US supreme court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion, while a lawsuit continues.
The justices are expected to issue an order on Wednesday in a fast-moving case from Texas in which abortion opponents are seeking to roll back Food and Drug Administration (FDA) approval of the drug, mifepristone.
The drug won FDA approval in 2000 and conditions on its use have been loosened in recent years, including making it available by mail in states that allow access.
The Biden administration and New York-based Danco Laboratories, the maker of the drug, want the highest court to reject limits on mifepristone use imposed by lower courts, at least as long as the legal case makes it way through the courts.
They say women who want the drug and providers who dispense it will face chaos if limits on the drug take effect. Depending on what the justices decide, that could include requiring women to take a higher dosage of the drug than the FDA says is necessary.
Alliance Defending Freedom, representing anti-abortion doctors and medical groups in a challenge to the drug, is defending the rulings in calling on the supreme court to let the restrictions take effect now.
